Key statistics
On Monday, Abeona Therapeutics Inc (ABEO:NAQ) closed at 6.54, -27.41% below its 52-week high of 9.01, set on Mar 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.51 |
---|---|
High | 6.73 |
Low | 6.39 |
Bid | 6.54 |
Offer | 6.80 |
Previous close | 6.46 |
Average volume | 304.16k |
---|---|
Shares outstanding | 43.31m |
Free float | 41.12m |
P/E (TTM) | -- |
Market cap | 279.81m USD |
EPS (TTM) | -2.13 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 21:00 BST.
More ▼
Announcements
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
- Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
- Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
- Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
- Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
- Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
- Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
More ▼